{
    "NCT05508789": {
        "inclusion_criteria_match": [
            "0",
            "10"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note mentions progressive memory loss and severe cognitive deficits, which are relevant to the study's focus on early Alzheimer's disease. The patient also has a study partner who will comply with the trial protocol, which meets the inclusion criteria.",
        "relevance_score_R": 80,
        "eligibility_explanation": "While the patient shows symptoms relevant to the study, the mention of jerking movements of the lower extremities and generalized periodic sharp waves on EEG suggest possible neurological conditions other than Alzheimer's disease, which could disqualify the patient based on the exclusion criteria.",
        "eligibility_score_E": -80
    },
    "NCT05026866": {
        "inclusion_criteria_match": [
            "No match"
        ],
        "exclusion_criteria_match": [
            "0",
            "1",
            "2",
            "3",
            "4",
            "5",
            "6",
            "7",
            "8",
            "9",
            "10"
        ],
        "relevance_explanation": "The patient's note indicates severe cognitive deficits and memory dysfunction, which are indicative of a more advanced stage of cognitive impairment. The neuroimaging and biopsy findings suggest a diagnosis more consistent with advanced neurodegenerative disease rather than preclinical Alzheimer's Disease. The patient also shows jerking movements of the lower extremities, which could indicate other neurological conditions.",
        "relevance_score_R": 10,
        "eligibility_explanation": "The patient's severe cognitive deficits and advanced neurodegenerative symptoms disqualify them from the trial, which is designed for participants with preclinical Alzheimer's Disease. Additionally, the patient's advanced disease stage and other neurological symptoms are not aligned with the inclusion criteria for preclinical Alzheimer's.",
        "eligibility_score_E": -10
    },
    "NCT06297590": {
        "inclusion_criteria_match": [
            "1",
            "2",
            "3",
            "4"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates progressive memory loss, cognitive deficits, and memory dysfunction, which are key symptoms of early symptomatic Alzheimer's Disease. The patient also shows compliance with the trial protocol, which is important for the study.",
        "relevance_score_R": 85,
        "eligibility_explanation": "The patient meets several inclusion criteria such as having gradual and progressive memory change, cognitive deficits, appropriate MMSE score, and clinical dementia rating. However, the note does not provide information on BMI, flortaucipir F18 PET criteria, or contraceptive requirements. The patient has a serious illness (neurologic examination confirms severe cognitive deficits), which is an exclusion criterion.",
        "eligibility_score_E": 50
    },
    "NCT06653153": {
        "inclusion_criteria_match": [
            "3",
            "5"
        ],
        "exclusion_criteria_match": [
            "1",
            "0"
        ],
        "relevance_explanation": "The patient has progressive memory loss and severe cognitive deficits, which are indicative of Alzheimer's Disease. The patient also has a reliable study partner and has adequate literacy, vision, and hearing for neuropsychological testing. However, the patient has severe cognitive deficits which may interfere with the study.",
        "relevance_score_R": 50,
        "eligibility_explanation": "The patient's severe cognitive deficits and dementia-like symptoms disqualify them from the trial based on the exclusion criteria. However, they meet some inclusion criteria related to having a reliable study partner and adequate literacy, vision, and hearing.",
        "eligibility_score_E": -50
    },
    "NCT06538116": {
        "inclusion_criteria_match": [
            "0",
            "1",
            "3",
            "4"
        ],
        "exclusion_criteria_match": [
            "0"
        ],
        "relevance_explanation": "The patient's note indicates a diagnosis consistent with Alzheimer's Disease, including progressive memory loss, cognitive deficits, and cerebral atrophy. The patient also has a reliable study partner who can provide consent and comply with the trial protocol.",
        "relevance_score_R": 85,
        "eligibility_explanation": "The patient meets several inclusion criteria but is excluded due to being of childbearing potential. The progressive memory loss and cognitive deficits are consistent with mild to moderate Alzheimer's Disease, but the exclusion criterion related to childbearing potential disqualifies the patient.",
        "eligibility_score_E": 42
    },
    "NCT06566170": {
        "inclusion_criteria_match": [
            "2",
            "4"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's note indicates progressive memory loss and severe cognitive deficits, which are relevant to the study of early symptomatic Alzheimer's Disease. The patient also has a reliable study partner and consents to the trial protocol.",
        "relevance_score_R": 80,
        "eligibility_explanation": "The patient does not meet the exclusion criteria and meets several inclusion criteria, such as having a reliable study partner and willingness to comply with the trial protocol. However, the patient's severe cognitive deficits and advanced cerebral atrophy suggest a more advanced stage of the disease, which may not fit the 'early symptomatic' criteria.",
        "eligibility_score_E": 60
    },
    "NCT06809400": {
        "inclusion_criteria_match": [
            "9",
            "10",
            "11"
        ],
        "exclusion_criteria_match": [
            "1",
            "2",
            "3",
            "4",
            "5",
            "6",
            "7",
            "8",
            "9",
            "10"
        ],
        "relevance_explanation": "The patient's note indicates a diagnosis of Parkinson's disease and cognitive deficits, which aligns with some inclusion criteria for participants with Parkinson's disease. However, the patient's age and symptoms also suggest significant neurological issues that could disqualify them from the trial.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient meets some inclusion criteria for having Parkinson's disease and cognitive assessment, but also meets several exclusion criteria due to significant neurological diseases and potential allergies or unstable conditions. Given these factors, the patient is unlikely to be eligible for the trial.",
        "eligibility_score_E": -40
    },
    "NCT06657768": {
        "inclusion_criteria_match": [
            "sentence id 5"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's note indicates that the patient has progressive memory loss, cognitive deficits, and other symptoms that are consistent with early symptomatic Alzheimer's Disease (AD). The patient also shows compliance with trial protocols, which is a positive aspect for participation.",
        "relevance_score_R": 85,
        "eligibility_explanation": "The patient's symptoms and neuroimaging findings are consistent with early symptomatic Alzheimer's Disease, which is a target inclusion criterion for Part B of the study. However, the patient's age and the absence of explicit mention of early symptomatic AD in the note make the eligibility less straightforward. The patient does not have any explicit exclusion criteria mentioned.",
        "eligibility_score_E": 70
    },
    "NCT06220669": {
        "inclusion_criteria_match": [
            "5"
        ],
        "exclusion_criteria_match": [],
        "relevance_explanation": "The patient's note mentions relapsing-remitting multiple sclerosis (RRMS) and an EDSS score \u2264 5.5, which aligns with the inclusion criteria for the clinical trial. However, the note does not provide information on relapses or active GdE brain lesions.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient has relapsing-remitting multiple sclerosis and an EDSS score \u2264 5.5, which meets the inclusion criteria. However, there is no information on recent relapses or active GdE brain lesions, which are also required for inclusion. The exclusion criteria are not met based on the provided information.",
        "eligibility_score_E": 40
    },
    "NCT06719128": {
        "inclusion_criteria_match": [
            "4"
        ],
        "exclusion_criteria_match": [
            "6",
            "7",
            "10",
            "11"
        ],
        "relevance_explanation": "The patient's note mentions a diagnosis of cerebral atrophy and severe cognitive deficits, which are neurological conditions. However, the patient also indicates compliance with the trial protocol, which is a positive inclusion criterion.",
        "relevance_score_R": 40,
        "eligibility_explanation": "The patient has a neurological condition that would exclude them from the trial due to the exclusion criteria. However, they are compliant with the trial protocol, which is a positive inclusion criterion. Given the severe neurological condition, the eligibility score is lower than the relevance score.",
        "eligibility_score_E": 20
    }
}